TWINRIX - 58160-815-52 - (Hepatitis A and Hepatitis B (Recombinant) Vaccine)

Alphabetical Index


Drug Information of TWINRIX

Product NDC: 58160-815
Proprietary Name: TWINRIX
Non Proprietary Name: Hepatitis A and Hepatitis B (Recombinant) Vaccine
Active Ingredient(s): 720; 20    [iU]/mL; ug/mL & nbsp;   Hepatitis A and Hepatitis B (Recombinant) Vaccine
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of TWINRIX

Product NDC: 58160-815
Labeler Name: GlaxoSmithKline Biologicals SA
Product Type: VACCINE
FDA Application Number: BLA103850
Marketing Category: BLA
Start Marketing Date: 20070607

Package Information of TWINRIX

Package NDC: 58160-815-52
Package Description: 10 SYRINGE in 1 CARTON (58160-815-52) > 1 mL in 1 SYRINGE (58160-815-43)

NDC Information of TWINRIX

NDC Code 58160-815-52
Proprietary Name TWINRIX
Package Description 10 SYRINGE in 1 CARTON (58160-815-52) > 1 mL in 1 SYRINGE (58160-815-43)
Product NDC 58160-815
Product Type Name VACCINE
Non Proprietary Name Hepatitis A and Hepatitis B (Recombinant) Vaccine
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 20070607
Marketing Category Name BLA
Labeler Name GlaxoSmithKline Biologicals SA
Substance Name HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN
Strength Number 720; 20
Strength Unit [iU]/mL; ug/mL
Pharmaceutical Classes Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of TWINRIX


General Information